Join
Live feed
·
INSIDERFilingvia Quantisnow
CAMP4 Therapeutics Corporation logo

Director Nashat Amir bought $9,999,990 worth of shares (909,090 units at $11.00) and converted options into 1,715,972 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CAMP· CAMP4 Therapeutics Corporation
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CAMP (CAMP4 Therapeutics Corporation) and more on Quantisnow.